Profiel
Paolo Galfetti is Chief Executive Officer & Director at APR Applied Pharma Research SA since 1995.
Mr. Galfetti is Chief Business Officer at Mindmaze Therapeutics Holding SA. Former roles include Chief Executive Officer & Director at Farma Resa Imp SRL, Chief Executive Officer & Director at Institute For Pharmacokinetic & Analytical Studies, and Chief Operating Officer at RELIEF THERAPEUTICS Holding SA from 2023 to 2024.
Education includes an undergraduate degree from the University of Bocconi.
Actieve functies van Paolo Galfetti
| Bedrijven | Functie | Begin |
|---|---|---|
APR Applied Pharma Research SA
APR Applied Pharma Research SA BiotechnologyHealth Technology Develops and licenses healthcare products and technologies | Algemeen Directeur | 01-01-1995 |
Eerdere bekende functies van Paolo Galfetti
| Bedrijven | Functie | Einde |
|---|---|---|
Institute For Pharmacokinetic & Analytical Studies | Algemeen Directeur | - |
Farma Resa Imp SRL
Farma Resa Imp SRL Pharmaceuticals: MajorHealth Technology Specializes in preparation of pharmaceutical tests | Algemeen Directeur | - |
| MINDMAZE THERAPEUTICS HOLDING SA | Operationeel Directeur | 08-05-2024 |
Opleiding van Paolo Galfetti
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
University of Bocconi
University of Bocconi Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Farma Resa Imp SRL
Farma Resa Imp SRL Pharmaceuticals: MajorHealth Technology Specializes in preparation of pharmaceutical tests | Health Technology |
APR Applied Pharma Research SA
APR Applied Pharma Research SA BiotechnologyHealth Technology Develops and licenses healthcare products and technologies | Health Technology |
RELIEF THERAPEUTICS Holding SA
RELIEF THERAPEUTICS Holding SA Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of biopharmaceutical products for respiratory diseases | Health Technology |
Institute For Pharmacokinetic & Analytical Studies |
















